About James Hardiman
Form D filings for Shennon Biotechnologies in 2023 list James Hardiman as director.
James Hardiman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name James Hardiman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Hardiman works with at each company, as listed on that company's latest Form D.
Shennon Biotechnologies Inc. · Form D, Mar 16, 2023
LS
Li Sun
Chief Executive Officer and director